Competitive inhibition of phosphodiesterase activity by amrinone: Its implication in the cardiac effect of the drug
- 1 October 1984
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 16 (10) , 969-977
- https://doi.org/10.1016/s0031-6989(84)80061-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Amrinone A Preliminary Review of its Pharmacological Properties and Therapeutic UseDrugs, 1983
- Electrical and Mechanical Effects of Amrinone on Isolated Guinea Pig Ventricular MuscleJournal of Cardiovascular Pharmacology, 1983
- Pharmacological actions of various inotropic agentsEuropean Heart Journal, 1983
- Long-term amrinone therapy in patients with severe heart failureThe American Journal of Medicine, 1982
- Effects of amrinone, a cardiotonic drug, on calcium movements in dog erythrocytes.Journal of Clinical Investigation, 1980
- Comments on "cardiotonic activity of amrinone-win 40680 [5-amino-3-4'-bypyridin-6(1H)-one]".Circulation Research, 1980
- Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failureThe American Journal of Cardiology, 1980
- The effects of amrinone on contractility, Ca2+ uptake and cAMP in smooth muscleEuropean Journal of Pharmacology, 1980
- Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].Circulation Research, 1979
- [30] Assay of cyclic nucleotide phosphodiesterases with radioactive substratesPublished by Elsevier ,1974